sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> acne drugs market

report

Acne Drugs Market, by Drug Class (Antibiotics, Anti-Inflammatory Drugs, Antimicrobial, Combination Medications, Hormonal Agents, Oral Retinoid, Topical Retinoid), Route of Administration (Oral, Topical), Type (OTC, Prescription) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

HC311 June 2017 100+ FREE 10% CUSTOMIZATION

Acne is one of the most common skin disease mainly transpires to teenagers. It occurs when hair follicles are blocked by oil from the skin also called as sebum with dead skin cells. The hyper active of hormones such as testosterone and excessive growth of Propionibacterium acne are considered the frequent factor for acne. Various treatments are available in the market to treat the condition which could be oral or topical. The most commonly used treatment is combination therapy. Globally it is estimated that 80 - 90% of teenagers are affected by acne to some degree. Major players in the market are focusing to develop medication to target the hormones responsible for high sebum production.

The report on the global Acne drugs market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The key reasons driving the growth of the acne drugs market includes high prevalence of acne across the globe, change in life style with increase in disposable income & psychological burden associated with acne, and increase in awareness about the available treatment in the market.
  • New effective combination drug therapy is one of the key growth opportunity drivers for this market.
  • However, factors like safety issues associated with the treatment and entry of generic drugs may hamper the growth of the acne drugs Market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s acne drugs market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the acne drugs market by the following segments:

  • Acne Drugs Market, by Drug Class
    • Antibiotics
    • Anti-Inflammatory Drugs
    • Antimicrobial
    • Combination Medications
    • Hormonal Agents
    • Oral Retinoid
    • Topical Retinoid
  • Acne Drugs Market, by Route Of Administration
    • Oral
    • Topical
  • Acne Drugs Market, by Type
    • OTC
    • Prescription

KEY MARKET PLAYERS

Key players in the acne drugs market include:

  • ALLERGAN
  • Cipher Pharmaceuticals Inc.
  • Galderma S.A.
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche Ltd
  • Stiefel Laboratories, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Valeant

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • ​​REST OF THE WORLD
    • ​​Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Orphan Drugs Market, by Type (Biological Orphan Drugs, Non-Biological Orphan Drugs), Therapeutic Area (Oncology, Neurology, Hematology, Infectious Disease, Metabolic Disease, and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. ACNE DRUGS MARKET, BY DRUG CLASS
    1. Segment Share
    2. Drug Class
      1. Antibiotics
      2. Anti-Inflammatory Drugs
      3. Antimicrobial
      4. Combination Medications
      5. Hormonal Agents
      6. Oral Retinoid
      7. Topical Retinoid
  6. ACNE DRUGS MARKET, BY ROUTE OF ADMINISTRATION
    1. Segment Share
    2. Route of Administration
      1. Oral
      2. Topical
  7. ACNE DRUGS MARKET, BY TYPE
    1. Segment Share
    2. Type
      1. OTC
      2. Prescription
  8. ACNE DRUGS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Drug Class
      3. By Route of Administration
      4. Type
    3. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Drug Class
      3. By Route of Administration
      4. Type
    4. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Drug Class
      3. By Route of Administration
      4. Type
    5. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Drug Class
      3. By Route of Administration
      4. Type
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  10. KEY MARKET PLAYERS
    1. ALLERGAN
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Cipher Pharmaceuticals Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Galderma S.A.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. GlaxoSmithKline plc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Johnson & Johnson Services, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Sun Pharmaceutical Industries Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. F. Hoffmann-La Roche Ltd
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Stiefel Laboratories, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Teva Pharmaceutical Industries Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Valeant
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX 
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us